Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$11.79 - $27.63 $33.3 Million - $78 Million
-2,823,215 Reduced 83.23%
568,785 $8.24 Million
Q4 2021

Feb 14, 2022

BUY
$36.68 - $54.02 $10.1 Million - $14.9 Million
275,700 Added 8.85%
3,392,000 $134 Million
Q3 2021

Nov 15, 2021

BUY
$49.57 - $58.15 $1.34 Million - $1.57 Million
27,083 Added 0.88%
3,116,300 $156 Million
Q2 2021

Aug 16, 2021

BUY
$47.17 - $58.64 $4.48 Million - $5.57 Million
94,917 Added 3.17%
3,089,217 $171 Million
Q1 2021

May 14, 2021

BUY
$42.51 - $54.07 $4.74 Million - $6.03 Million
111,600 Added 3.87%
2,994,300 $140 Million
Q3 2020

Nov 13, 2020

BUY
$28.55 - $36.91 $39.6 Million - $51.2 Million
1,386,500 Added 92.67%
2,882,700 $106 Million
Q2 2020

Aug 14, 2020

BUY
$24.0 - $32.87 $31.2 Million - $42.7 Million
1,300,000 Added 662.59%
1,496,200 $43.6 Million
Q4 2019

Feb 18, 2020

SELL
$26.44 - $40.63 $711,236 - $1.09 Million
-26,900 Reduced 12.06%
196,200 $6.81 Million
Q3 2019

Nov 14, 2019

BUY
$30.31 - $48.63 $6.76 Million - $10.8 Million
223,100 New
223,100 $7.06 Million

Others Institutions Holding HCAT

About Health Catalyst, Inc.


  • Ticker HCAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 54,723,400
  • Market Cap $378M
  • Description
  • Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...
More about HCAT
Track This Portfolio

Track Capital Research Global Investors Portfolio

Follow Capital Research Global Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.